NIH, DHHS: Cancer Trends Progress Report - 2007 Update. Bethesda, MD. 2007, [http://progressreport.cancer.gov/]
Google Scholar
Pfister DG, Johnson DH, Azzoli CG, Sause W, Smith TJ, Baker S, Olak J, Stover D, Strawn JR, Turrisi AT, Somerfield MR: American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol. 2004, 22 (2): 330-353. 10.1200/JCO.2004.09.053.
Article
PubMed
Google Scholar
Dempke WCM, Suto T, Reck M: Targeted therapies for non-small cell lung cancer. Lung Cancer. 2009, 67 (3): 257-274. 10.1016/j.lungcan.2009.10.012.
Article
PubMed
Google Scholar
Müller-Hagen G, Beinert T, Sommer A: Aspects of lung cancer gene expression profiling. Curr Opin Drug Discov Devel. 2004, 7 (3): 290-303.
PubMed
Google Scholar
Fichtner I, Rol J, Soong R, Homann J, Hammer S, Sommer A, Becker M, Merk J: Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkers. Clin Cancer Res. 2008, 14 (20): 6456-6468. 10.1158/1078-0432.CCR-08-0138.
Article
CAS
PubMed
Google Scholar
Hammer S, Sommer A, Fichtner I, Becker M, Rol J, Merk J, Klar U, Homann J: Comparative Profiling of the Novel Epothilone, Sagopilone, in Xenografts Derived from Primary Non-Small Cell Lung Cancer. Clin Cancer Res. 2010, 16 (5): 1452-1465. 10.1158/1078-0432.CCR-09-2455.
Article
CAS
PubMed
Google Scholar
Dehan E, Ben-Dor A, Liao W, Lipson D, Frimer H, Rienstein S, Simansky D, Krupsky M, Yaron P, Friedman E, Rechavi G, Perlman M, Aviram-Goldring A, Izraeli S, Bittner M, Yakhini Z, Kaminski N: Chromosomal aberrations and gene expression profiles in non-small cell lung cancer. Lung Cancer. 2007, 56 (2): 175-184. 10.1016/j.lungcan.2006.12.010.
Article
CAS
PubMed
Google Scholar
Smith IM, Glazer CA, Mithani SK, Ochs MF, Sun W, Bhan S, Vostrov A, Abdullaev Z, Lobanenkov V, Gray A, Liu C, Chang SS, Ostrow KL, Westra WH, Begum S, Dhara M, Califano J: Coordinated activation of candidate proto-oncogenes and cancer testes antigens via promoter demethylation in head and neck cancer and lung cancer. PLoS One. 2009, 4 (3): e4961-10.1371/journal.pone.0004961.
Article
PubMed Central
PubMed
Google Scholar
Nilsen TW, Graveley BR: Expansion of the eukaryotic proteome by alternative splicing. Nature. 2010, 463: 457-463. 10.1038/nature08909.
Article
CAS
PubMed Central
PubMed
Google Scholar
Matlin AJ, Clark F, Smith CWJ: Understanding alternative splicing: towards a cellular code. Nat Rev Mol Cell Biol. 2005, 6 (5): 386-398. 10.1038/nrm1645.
Article
CAS
PubMed
Google Scholar
Johnson JM, Castle J, Garrett-Engele P, Kan Z, Loerch PM, Armour CD, Santos R, Schadt EE, Stoughton R, Shoemaker DD: Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science. 2003, 302 (5653): 2141-2144. 10.1126/science.1090100.
Article
CAS
PubMed
Google Scholar
Kampa D, Cheng J, Kapranov P, Yamanaka M, Brubaker S, Cawley S, Drenkow J, Piccolboni A, Bekiranov S, Helt G, Tammana H, Gingeras TR: Novel RNAs identified from an in-depth analysis of the transcriptome of human chromosomes 21 and 22. Genome Res. 2004, 14 (3): 331-342. 10.1101/gr.2094104.
Article
CAS
PubMed Central
PubMed
Google Scholar
Venables JP: Unbalanced alternative splicing and its significance in cancer. Bioessays. 2006, 28 (4): 378-386. 10.1002/bies.20390.
Article
CAS
PubMed
Google Scholar
Hayes GM, Carrigan PE, Miller LJ: Serine-arginine protein kinase 1 overexpression is associated with tumorigenic imbalance in mitogen-activated protein kinase pathways in breast, colonic, and pancreatic carcinomas. Cancer Res. 2007, 67 (5): 2072-2080. 10.1158/0008-5472.CAN-06-2969.
Article
CAS
PubMed
Google Scholar
Ngo JCK, Chakrabarti S, Ding JH, Velazquez-Dones A, Nolen B, Aubol BE, Adams JA, Fu XD, Ghosh G: Interplay between SRPK and Clk/Sty kinases in phosphorylation of the splicing factor ASF/SF2 is regulated by a docking motif in ASF/SF2. Mol Cell. 2005, 20: 77-89. 10.1016/j.molcel.2005.08.025.
Article
CAS
PubMed
Google Scholar
Karni R, de Stanchina E, Lowe SW, Sinha R, Mu D, Krainer AR: The gene encoding the splicing factor SF2/ASF is a proto-oncogene. Nat Struct Mol Biol. 2007, 14 (3): 185-193. 10.1038/nsmb1209.
Article
CAS
PubMed Central
PubMed
Google Scholar
Kim E, Goren A, Ast G: Insights into the connection between cancer and alternative splicing. Trends Genet. 2008, 24: 7-10. 10.1016/j.tig.2007.10.001.
Article
CAS
PubMed
Google Scholar
Spellman R, Llorian M, Smith CWJ: Crossregulation and functional redundancy between the splicing regulator PTB and its paralogs nPTB and ROD1. Mol Cell. 2007, 27 (3): 420-434. 10.1016/j.molcel.2007.06.016.
Article
CAS
PubMed Central
PubMed
Google Scholar
Heiner M, Hui J, Schreiner S, Hung LH, Bindereif A: HnRNP L-mediated regulation of mammalian alternative splicing by interference with splice site recognition. RNA Biol. 2010, 7: 56-64. 10.4161/rna.7.1.10402.
Article
CAS
PubMed
Google Scholar
Akgul C, Moulding DA, Edwards SW: Alternative splicing of Bcl-2-related genes: functional consequences and potential therapeutic applications. Cell Mol Life Sci. 2004, 61 (17): 2189-2199. 10.1007/s00018-004-4001-7.
Article
CAS
PubMed
Google Scholar
Ponta H, Sherman L, Herrlich PA: CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol. 2003, 4: 33-45. 10.1038/nrm1004.
Article
CAS
PubMed
Google Scholar
Tremmel M, Matzke A, Albrecht I, Laib AM, Olaku V, Ballmer-Hofer K, Christofori G, Héroult M, Augustin HG, Ponta H, Orian-Rousseau V: A CD44v6 peptide reveals a role of CD44 in VEGFR-2 signaling and angiogenesis. Blood. 2009, 114 (25): 5236-5244. 10.1182/blood-2009-04-219204.
Article
CAS
PubMed
Google Scholar
Riechelmann H, Sauter A, Golze W, Hanft G, Schroen C, Hoermann K, Erhardt T, Gronau S: Phase I trial with the CD44v6-targeting immunoconjugate bivatuzumab mertansine in head and neck squamous cell carcinoma. Oral Oncol. 2008, 44 (9): 823-829. 10.1016/j.oraloncology.2007.10.009.
Article
CAS
PubMed
Google Scholar
Castellani P, Viale G, Dorcaratto A, Nicolo G, Kaczmarek J, Querze G, Zardi L: The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis. Int J Cancer. 1994, 59 (5): 612-618. 10.1002/ijc.2910590507.
Article
CAS
PubMed
Google Scholar
Berndor D, Borkowski S, Sieger S, Rother A, Friebe M, Viti F, Hilger CS, Cyr JE, Dinkelborg LM: Radioimmunotherapy of solid tumors by targeting extra domain B fibronectin: identification of the best-suited radioimmunoconjugate. Clin Cancer Res. 2005, 11 (19 Suppl): 7053s-7063s. 10.1158/1078-0432.CCR-1004-0015.
Article
Google Scholar
Hanahan D, Weinberg RA: The hallmarks of cancer. Cell. 2000, 100: 57-70. 10.1016/S0092-8674(00)81683-9.
Article
CAS
PubMed
Google Scholar
Gardina PJ, Clark TA, Shimada B, Staples MK, Yang Q, Veitch J, Schweitzer A, Awad T, Sugnet C, Dee S, Davies C, Williams A, Turpaz Y: Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array. BMC Genomics. 2006, 7: 325-10.1186/1471-2164-7-325.
Article
PubMed Central
PubMed
Google Scholar
Hallegger M, Llorian M, Smith CWJ: Alternative splicing: global insights. FEBS J. 2010, 277 (4): 856-866. 10.1111/j.1742-4658.2009.07521.x.
Article
CAS
PubMed
Google Scholar
Clark TA, Schweitzer AC, Chen TX, Staples MK, Lu G, Wang H, Williams A, Blume JE: Discovery of tissue-specific exons using comprehensive human exon microarrays. Genome Biol. 2007, 8 (4): R64-10.1186/gb-2007-8-4-r64.
Article
PubMed Central
PubMed
Google Scholar
Zhang W, Duan S, Bleibel WK, Wisel SA, Huang RS, Wu X, He L, Clark TA, Chen TX, Schweitzer AC, Blume JE, Dolan ME, Cox NJ: Identification of common genetic variants that account for transcript isoform variation between human populations. Hum Genet. 2009, 125: 81-93. 10.1007/s00439-008-0601-x.
Article
CAS
PubMed Central
PubMed
Google Scholar
Hang X, Li P, Li Z, Qu W, Yu Y, Li H, Shen Z, Zheng H, Gao Y, Wu Y, Deng M, Sun Z, Zhang C: Transcription and splicing regulation in human umbilical vein endothelial cells under hypoxic stress conditions by exon array. BMC Genomics. 2009, 10: 126-10.1186/1471-2164-10-126.
Article
PubMed Central
PubMed
Google Scholar
Thorsen K, Sørensen KD, Brems-Eskildsen AS, Modin C, Gaustadnes M, Hein AMK, Kruhøer M, Laurberg S, Borre M, Wang K, Brunak S, Krainer AR, Tørring N, Dyrskjøt L, Andersen CL, Orntoft TF: Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis. Mol Cell Proteomics. 2008, 7 (7): 1214-1224. 10.1074/mcp.M700590-MCP200.
Article
CAS
PubMed
Google Scholar
Möller-Levet CS, Betts GNJ, Harris AL, Homer JJ, West CML, Miller CJ: Exon array analysis of head and neck cancers identifies a hypoxia related splice variant of LAMA3 Associated with a poor prognosis. PLoS Comput Biol. 2009, 5 (11): e1000571-10.1371/journal.pcbi.1000571.
Article
PubMed Central
PubMed
Google Scholar
Xi L, Feber A, Gupta V, Wu M, Bergemann AD, Landreneau RJ, Litle VR, Pennathur A, Luketich JD, Godfrey TE: Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer. Nucleic Acids Res. 2008, 36 (20): 6535-6547. 10.1093/nar/gkn697.
Article
CAS
PubMed Central
PubMed
Google Scholar
Lin E, Li L, Guan Y, Soriano R, Rivers CS, Mohan S, Pandita A, Tang J, Modrusan Z: Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers. Mol Cancer Res. 2009, 7 (9): 1466-1476. 10.1158/1541-7786.MCR-08-0522.
Article
CAS
PubMed
Google Scholar
Affymetrix: Identifying and Validating Alternative Splicing Events. 2006, [http://www.affymetrix.com/support/technical/technotes/id_altsplicingevents_technote.pdf]
Google Scholar
Okoniewski MJ, Hey Y, Pepper SD, Miller CJ: High correspondence between Affymetrix exon and standard expression arrays. Biotechniques. 2007, 42 (2): 181-185. 10.2144/000112315.
Article
CAS
PubMed
Google Scholar
Affymetrix: Exon Array Background Correction. 2005, [http://www.affymetrix.com/support/technical/whitepapers/exon_background_correction_whitepaper.pdf]
Google Scholar
Kapur K, Xing Y, Ouyang Z, Wong WH: Exon arrays provide accurate assessments of gene expression. Genome Biol. 2007, 8 (5): R82-10.1186/gb-2007-8-5-r82.
Article
PubMed Central
PubMed
Google Scholar
Furusawa C, Ono N, Suzuki S, Agata T, Shimizu H, Yomo T: Model-based analysis of non-specific binding for background correction of high-density oligonucleotide microarrays. Bioinformatics. 2009, 25: 36-41. 10.1093/bioinformatics/btn570.
Article
CAS
PubMed
Google Scholar
Bea CD, Cordero F, Calogero RA: Dissecting an alternative splicing analysis workflow for GeneChip Exon 1.0 ST Affymetrix arrays. BMC Genomics. 2008, 9: 571-10.1186/1471-2164-9-571.
Article
Google Scholar
Affymetrix: Gene Signal Estimates from Exon Arrays. 2005, [http://www.affymetrix.com/support/technical/whitepapers/exon_gene_signal_estimate_whitepaper.pdf]
Google Scholar
Xing Y, Kapur K, Wong WH: Probe selection and expression index computation of Affymetrix Exon Arrays. PLoS ONE. 2006, 1: e88-10.1371/journal.pone.0000088.
Article
PubMed Central
PubMed
Google Scholar
Xing Y, Stoilov P, Kapur K, Han A, Jiang H, Shen S, Black DL, Wong WH: MADS: a new and improved method for analysis of differential alternative splicing by exon-tiling microarrays. RNA. 2008, 14 (8): 1470-1479. 10.1261/rna.1070208.
Article
CAS
PubMed Central
PubMed
Google Scholar
Shah SH, Pallas JA: Identifying differential exon splicing using linear models and correlation coecients. BMC Bioinformatics. 2009, 10: 26-10.1186/1471-2105-10-26.
Article
PubMed Central
PubMed
Google Scholar
Yates T, Okoniewski MJ, Miller CJ: X:Map: annotation and visualization of genome structure for Affymetrix exon array analysis. Nucleic Acids Res. 2008, D780-D786. 36 Database
Okoniewski MJ, Yates T, Dibben S, Miller CJ: An annotation infrastructure for the analysis and interpretation of Affymetrix exon array data. Genome Biol. 2007, 8 (5): R79-10.1186/gb-2007-8-5-r79.
Article
PubMed Central
PubMed
Google Scholar
Okoniewski MJ, Miller CJ: Comprehensive analysis of Affymetrix exon arrays using BioConductor. PLoS Comput Biol. 2008, 4 (2): e6-10.1371/journal.pcbi.0040006.
Article
PubMed Central
PubMed
Google Scholar
Affymetrix: Alternative Transcript Analysis Methods for Exon Arrays. 2005, [http://www.affymetrix.com/support/technical/whitepapers/exon_alt_transcript_analysis_whitepaper.pdf]
Google Scholar
Smit AFA, G P, Hubley R: RepeatMasker Open-3.0. 1996, [http://www.repeatmasker.org/]
Google Scholar
Rozen S, Skaletsky H: Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol. 2000, 132: 365-386.
CAS
PubMed
Google Scholar
Vandesompele J, Preter KD, Pattyn F, Poppe B, Roy NV, Paepe AD, Speleman F: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3 (7): research0034.1-0034.11. 10.1186/gb-2002-3-7-research0034.
Article
Google Scholar
Saviozzi S, Cordero F, Iacono ML, Novello S, Scagliotti GV, Calogero RA: Selection of suitable reference genes for accurate normalization of gene expression profile studies in non-small cell lung cancer. BMC Cancer. 2006, 6: 200-10.1186/1471-2407-6-200.
Article
PubMed
Google Scholar
Hubbell E, Liu WM, Mei R: Robust estimators for expression analysis. Bioinformatics. 2002, 18 (12): 1585-1592. 10.1093/bioinformatics/18.12.1585.
Article
CAS
PubMed
Google Scholar
Venables JP, Klinck R, Koh C, Gervais-Bird J, Bramard A, Inkel L, Durand M, Couture S, Froehlich U, Lapointe E, Lucier JF, Thibault P, Rancourt C, Tremblay K, Prinos P, Chabot B, Elela SA: Cancer-associated regulation of alternative splicing. Nat Struct Mol Biol. 2009, 16 (6): 670-676. 10.1038/nsmb.1608.
Article
CAS
PubMed
Google Scholar
Baraniak AP, Chen JR, Garcia-Blanco MA: Fox-2 mediates epithelial cell-specific fibroblast growth factor receptor 2 exon choice. Mol Cell Biol. 2006, 26 (4): 1209-1222. 10.1128/MCB.26.4.1209-1222.2006.
Article
CAS
PubMed Central
PubMed
Google Scholar
Nakahata S, Kawamoto S: Tissue-dependent isoforms of mammalian Fox-1 homologs are associated with tissue-specific splicing activities. Nucleic Acids Res. 2005, 33 (7): 2078-2089. 10.1093/nar/gki338.
Article
CAS
PubMed Central
PubMed
Google Scholar
Dutertre M, Lacroix-Triki M, Driouch K, de la Grange P, Gratadou L, Beck S, Millevoi S, Tazi J, Lidereau R, Vagner S, Auboeuf D: Exon-Based Clustering of Murine Breast Tumor Transcriptomes Reveals Alternative Exons Whose Expression Is Associated with Metastasis. Cancer Res. 2010, 70 (3): 896-905. 10.1158/0008-5472.CAN-09-2703.
Article
CAS
PubMed
Google Scholar
Raval GN, Bharadwaj S, Levine EA, Willingham MC, Geary RL, Kute T, Prasad GL: Loss of expression of tropomyosin-1, a novel class II tumor suppressor that induces anoikis, in primary breast tumors. Oncogene. 2003, 22 (40): 6194-6203. 10.1038/sj.onc.1206719.
Article
CAS
PubMed
Google Scholar
Okumura M, Kondo S, Ogata M, Kanemoto S, Murakami T, Yanagida K, Saito A, Imaizumi K: Candidates for tumor-specific alternative splicing. Biochem Biophys Res Commun. 2005, 334: 23-29. 10.1016/j.bbrc.2005.06.057.
Article
CAS
PubMed
Google Scholar
Goodson M, Jonas BA, Privalsky MA: Corepressors: custom tailoring and alterations while you wait. Nucl Recept Signal. 2005, 3: e003-10.1621/nrs.03003.
Article
PubMed Central
PubMed
Google Scholar
Yeo GW, Coufal NG, Liang TY, Peng GE, Fu XD, Gage FH: An RNA code for the FOX2 splicing regulator revealed by mapping RNA-protein interactions in stem cells. Nat Struct Mol Biol. 2009, 16 (2): 130-137. 10.1038/nsmb.1545.
Article
CAS
PubMed Central
PubMed
Google Scholar
Ge X, Yamamoto S, Tsutsumi S, Midorikawa Y, Ihara S, Wang SM, Aburatani H: Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics. 2005, 86 (2): 127-141. 10.1016/j.ygeno.2005.04.008.
Article
CAS
PubMed
Google Scholar
Underwood JG, Boutz PL, Dougherty JD, Stoilov P, Black DL: Homologues of the Caenorhabditis elegans Fox-1 protein are neuronal splicing regulators in mammals. Mol Cell Biol. 2005, 25 (22): 10005-10016. 10.1128/MCB.25.22.10005-10016.2005.
Article
CAS
PubMed Central
PubMed
Google Scholar
Norris JD, Fan D, Sherk A, McDonnell DP: A negative coregulator for the human ER. Mol Endocrinol. 2002, 16 (3): 459-468. 10.1210/me.16.3.459.
Article
CAS
PubMed
Google Scholar
Romana SP, Radford-Weiss I, Abdelali RB, Schluth C, Petit A, Dastugue N, Talmant P, Bilhou-Nabera C, Mugneret F, Lafage-Pochitalo M, Mozziconacci MJ, Andrieu J, Lai JL, Terre C, Rack K, Cornillet-Lefebvre P, Luquet I, Nadal N, Nguyen-Khac F, Perot C, den Akker JV, Fert-Ferrer S, Cabrol C, Charrin C, Tigaud I, Poirel H, Vekemans M, Bernard OA, Berger R, de Cytogénétique Hématologique GF: NUP98 rearrangements in hematopoietic malignancies: a study of the Groupe Francophone de Cytogénétique Hématologique. Leukemia. 2006, 20 (4): 696-706. 10.1038/sj.leu.2404130.
Article
CAS
PubMed
Google Scholar
Bennett V, Baines AJ: Spectrin and ankyrin-based pathways: metazoan inventions for integrating cells into tissues. Physiol Rev. 2001, 81 (3): 1353-1392.
CAS
PubMed
Google Scholar
Matsuoka Y, Li X, Bennett V: Adducin: structure, function and regulation. Cell Mol Life Sci. 2000, 57 (6): 884-895. 10.1007/PL00000731.
Article
CAS
PubMed
Google Scholar